Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001289036 | SCV001476574 | uncertain significance | not provided | 2020-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001835375 | SCV002187269 | benign | Nemaline myopathy 2 | 2025-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002543001 | SCV003646433 | uncertain significance | Inborn genetic diseases | 2022-10-12 | criteria provided, single submitter | clinical testing | The c.2683G>A (p.A895T) alteration is located in exon 28 (coding exon 26) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 2683, causing the alanine (A) at amino acid position 895 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001835375 | SCV002077777 | uncertain significance | Nemaline myopathy 2 | 2020-01-24 | no assertion criteria provided | clinical testing |